| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.4M | -21.5% |
| SG&A Expense | $14.2M | -47.9% |
| Operating Income | -$27.8M | +37.2% |
| Interest Expense | $120K | — |
| Net Income | -$30.1M | +24.2% |
| EPS (Basic) | -$0.40 | +33.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -77.1% |
| Accounts Receivable | $270K | +3757.1% |
| Current Assets | $6.9M | -73.3% |
| Total Assets | $7.3M | -71.7% |
| Current Liabilities | $19.0M | +22.2% |
| Long-term Debt | $9.2M | -13.0% |
| Total Liabilities | $19.0M | +3.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.7M | +45.5% |
| Investing Cash Flow | -$3K | +70.0% |
| Financing Cash Flow | $6.2M | -80.8% |
| Stockholders' Equity |
| -$11.7M |
| -258.4% |